Skip to main content
. 2013 Feb 7;24(3):498–505. doi: 10.1681/ASN.2012060595

Table 1.

Baseline characteristics

Variable Daily Trial Nocturnal Trial
Conventional (n=120) Daily (n=125) All (n=245) Conventional (n=42) Nocturnal (n=45) All (n=87)
Age (yr) 52.0±14.1 48.9±13.6 50.4±13.9 54.0±12.9 51.7±14.4 52.8±13.6
Male sex 73 (60.8) 78 (62.4) 151 (61.6) 28 (66.7) 29 (64.4) 57 (65.5)
Race/ethnicity
 Black 53 (44.2) 49 (39.2) 102 (41.6) 11 (26.2) 12 (26.7) 23(26.4)
 White 46 (38.3) 43 (34.4) 89 (36.3) 21 (50.0) 27 (60.0) 48 (55.2)
 Native American, aboriginal Canadian, Alaska Native, First Nation 4 (3.3) 4 (3.2) 8 (3.3) 2 (4.8) 1 (2.2) 3 (3.4)
 Asian 5 (4.2) 11 (8.8) 16 (6.5) 7 (16.7) 5 (11.1) 12 (13.8)
 Native Hawaiian/other Pacific Islander 3 (2.5) 1 (0.8) 4 (1.6) 0 (0) 0 (0) 0 (0)
 Other/mixed/unknown 9 (7.5) 17 (13.6) 26 (10.5) 1 (2.4) 0 (0) 1 (1.2)
 Hispanic/Latino 31 (26) 38 (30) 69 (28.2) 0 (0) 0 (0) 0 (0)
ESRD vintage
 <2 yr 35 (29.2) 37 (29.6) 72 (29.4) 30 (71.4) 28 (62.2) 58 (66.7)
 2–5 yr 42 (35.0) 34 (27.2) 76 (31.0) 5 (11.9) 8 (17.8) 13 (14.9)
 >5 yr 43 (35.8) 54 (43.2) 97 (39.6) 7 (16.7) 9 (20.0) 16 (18.4)
Comorbid conditions
 Diabetes 50 (41.7) 50 (40.0) 100 (40.8) 18 (42.9) 19 (42.2) 37 (42.5)
 Congestive heart failure 24 (20) 25 (20) 49 (20.0) 7 (16.7) 5 (11.1) 12 (13.8)
Laboratory values
 Albumin (g/dl) 3.94±0.46 3.94±0.37 3.94±0.42 3.92±0.51 3.90±0.48 3.91±0.49
 Hemoglobin (g/dl) 12.0±1.2 11.9±1.3 11.9±1.3 11.9±1.1 11.6±1.1 11.8±1.1
Vascular access used at randomization
 Arteriovenous fistula 71 (59) 82 (66) 153 (63) 17 (40) 22 (49) 39 (45)
 Arteriovenous graft 23 (19) 22 (18) 45 (18) 4 (10) 3 (7) 7 (8)
 Tunneled catheter 26 (22) 21 (17) 47 (19) 21 (50) 20 (44) 41 (47)
Buttonhole technique used (n) 14 19 33

Unless otherwise indicated, values are expressed as number of patients (percentage). Values expressed with a plus/minus sign are the mean ± SD.